GC-MS尿液类固醇代谢组分析区分儿童肾上腺皮质肿瘤:MET研究观察
该研究纳入46例初诊儿童肾上腺皮质肿瘤患者,采用靶向GC-MS定量尿液中36种C21、C19、C18类固醇代谢物,并结合机器学习分析。结果显示患儿与对照多数参数差异显著,Δ5类固醇代谢物及THS明显升高,且所选标志物可高敏感、高特异地区分肿瘤与对照及腺瘤与癌。
要点
- 尿GC-MS类固醇代谢组分析可无创检测儿童肾上腺皮质肿瘤。
- Δ5类固醇(孕烯醇酮、17-羟孕烯醇酮、DHEA)及THS在患儿中显著升高。
- 所选标志物可高敏感、高特异地鉴别儿童肾上腺皮质癌与腺瘤。
核心结论
- 尿GC-MS类固醇代谢组分析可无创地从 spot 尿中良好检测儿童肾上腺皮质肿瘤。
- 该分析可良好区分儿童肾上腺皮质癌与儿童肾上腺皮质腺瘤。
- Δ5类固醇在儿童肾上腺皮质肿瘤中占优势,提示网状带为共同起源部位。
- 区分儿童腺瘤与癌的参数与成人不同。
研究设计与样本
- 研究纳入46例初诊儿童肾上腺皮质肿瘤患者(中位年龄6.9岁,范围0.7-17岁;36例女性;21例腺瘤,25例癌),来自德国儿童肿瘤与血液肿瘤学会恶性内分泌肿瘤研究。
- 采用靶向GC-MS从spot尿中定量36种尿液C21、C19、C18类固醇代谢物。
- 数据经对数转换、z转换后,采用聚类分析、主成分分析、逻辑回归和决策树等机器学习分类器分析。
主要发现
- 儿童肾上腺皮质肿瘤与对照在多数参数上差异高度显著(P < .001)。
- Δ5类固醇孕烯醇酮、17-羟孕烯醇酮和脱氢表雄酮的尿液代谢物以及THS(11-脱氧皮质醇的尿液主要代谢物)明显升高。
- 儿童肾上腺皮质癌显示THS较高、皮质酮代谢物降低(P < .05)。
- 所选生物标志物以高敏感性和高特异性区分儿童肾上腺皮质肿瘤与对照,以及儿童肾上腺皮质癌与儿童肾上腺皮质腺瘤。
关键数值与推荐
- 儿童肾上腺皮质肿瘤与对照多数参数差异P < .001。
- 儿童肾上腺皮质癌与腺瘤比较:THS较高、皮质酮代谢物降低,P < .05。
临床怎么用
- 尿GC-MS类固醇代谢组分析可作为儿童肾上腺皮质肿瘤无创检测与腺瘤/癌鉴别的辅助手段。
- 解读儿童肾上腺皮质肿瘤标志物时需注意其与成人不同。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Adrenocortical tumors (ACTs) comprise adrenocortical adenomas (ACAs) and adrenocortical carcinomas (ACCs); the latter are highly aggressive. Pediatric adrenocortical tumors (pACTs) are functional and thus symptomatic. We investigated whether gas chromatography-mass spectrometry (GC-MS) urinary steroid metabolome analysis can detect tumors and differentiate between adenomas and carcinomas. METHOD: We investigated 46 patients with pACTs (age: median 6.9; range 0.7-17 years; 36 females; 21 ACAs, 25 ACCs) from the German Society for Pediatric Oncology and Hematology for Malignant Endocrine Tumors study at the time of initial diagnosis. Thirty-six urinary C21-, C19-, and C18-steroid metabolites were quantified from spot urines by targeted GC-MS. Data underwent computational analysis by log transformation followed by z-transformation and machine learning classifiers, such as cluster and principal component analysis, logistic regression, and decision trees. RESULTS: pACTs and controls showed highly significant differences (P < .001) for most parameters, particularly gross elevation of the urinary metabolites of the Δ5-steroids pregnenolone, 17-hydroxypregnenolone, and dehydroepiandrosterone, as well as of tetrahydro-11-deoxycortisol (THS), the urinary main metabolite of 11-deoxycortisol. Pediatric adrenocortical carcinomas (pACCs) showed higher THS and decreased corticosterone metabolites (P < .05). Selected biomarkers discriminated pACTs from controls, as well as pACCs from pediatric adrenocortical adenomas (pACAs) with high sensitivity and specificity. CONCLUSION: Urinary GC-MS steroid metabolome analysis is noninvasive and allows good detection of ACTs from spot urine as well as good differentiation of pACCs from pACAs. The dominance of Δ5-steroids in pACTs points to the zona reticularis as a common site of origin. The parameters differentiating pACAs from pACCs differ from adults.
引用
- Wudy SA, Pons-Kühnemann J, Kunstreich M, et al. Delineating Pediatric Adrenocortical Tumors by GC-MS Urinary Steroid Metabolome Analysis: Observations From the MET Study. J Clin Endocrinol Metab. 2026. PMID: 41225718. doi:10.1210/clinem/dgaf613
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。